

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 5.57286948 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 5.57286948 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.57286948 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.57286948 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.57286948 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.57286948 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.02597252 |
| 8 | response to peptidoglycan (GO:0032494) | 4.71459913 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 4.64873527 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.51337019 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.51337019 |
| 12 | leukocyte aggregation (GO:0070486) | 4.48768291 |
| 13 | detection of molecule of bacterial origin (GO:0032490) | 4.47289079 |
| 14 | germinal center formation (GO:0002467) | 4.37864214 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 4.36399805 |
| 16 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.35623771 |
| 17 | positive regulation of mast cell degranulation (GO:0043306) | 4.35623771 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.34133812 |
| 19 | cellular extravasation (GO:0045123) | 4.29573176 |
| 20 | immunoglobulin mediated immune response (GO:0016064) | 4.24537238 |
| 21 | detection of other organism (GO:0098543) | 4.15040392 |
| 22 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.10096824 |
| 23 | positive regulation of mast cell activation (GO:0033005) | 4.09003303 |
| 24 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.02001607 |
| 25 | response to muramyl dipeptide (GO:0032495) | 4.01198708 |
| 26 | microglial cell activation (GO:0001774) | 3.96847554 |
| 27 | tolerance induction (GO:0002507) | 3.90036722 |
| 28 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.86406367 |
| 29 | regulation of mast cell degranulation (GO:0043304) | 3.85984561 |
| 30 | respiratory burst (GO:0045730) | 3.84393226 |
| 31 | regulation of gamma-delta T cell activation (GO:0046643) | 3.81494072 |
| 32 | T-helper 1 type immune response (GO:0042088) | 3.76779175 |
| 33 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.76459964 |
| 34 | negative regulation of interleukin-12 production (GO:0032695) | 3.75075853 |
| 35 | positive regulation of interferon-alpha production (GO:0032727) | 3.72121280 |
| 36 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.71952366 |
| 37 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.69060158 |
| 38 | detection of external biotic stimulus (GO:0098581) | 3.66605661 |
| 39 | neutrophil mediated immunity (GO:0002446) | 3.64319800 |
| 40 | response to host immune response (GO:0052572) | 3.61015868 |
| 41 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.61015868 |
| 42 | regulation of interferon-alpha production (GO:0032647) | 3.58372137 |
| 43 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.58362695 |
| 44 | interferon-gamma production (GO:0032609) | 3.57871850 |
| 45 | positive regulation of heat generation (GO:0031652) | 3.56918578 |
| 46 | detection of bacterium (GO:0016045) | 3.55704353 |
| 47 | myeloid cell activation involved in immune response (GO:0002275) | 3.54618550 |
| 48 | neutrophil activation (GO:0042119) | 3.53748459 |
| 49 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.53056436 |
| 50 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.52979718 |
| 51 | positive regulation of B cell differentiation (GO:0045579) | 3.52574537 |
| 52 | regulation of fever generation (GO:0031620) | 3.51042000 |
| 53 | detection of biotic stimulus (GO:0009595) | 3.48533699 |
| 54 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.47963840 |
| 55 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.46502411 |
| 56 | granulocyte activation (GO:0036230) | 3.42535038 |
| 57 | neutrophil chemotaxis (GO:0030593) | 3.42504540 |
| 58 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.37451987 |
| 59 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.36757453 |
| 60 | response to host (GO:0075136) | 3.36757453 |
| 61 | response to host defenses (GO:0052200) | 3.36757453 |
| 62 | positive regulation of antigen processing and presentation (GO:0002579) | 3.36066539 |
| 63 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.34862302 |
| 64 | negative regulation of cell killing (GO:0031342) | 3.34862302 |
| 65 | positive regulation of leukocyte degranulation (GO:0043302) | 3.34091800 |
| 66 | neutrophil migration (GO:1990266) | 3.33659816 |
| 67 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.33525331 |
| 68 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.30383936 |
| 69 | regulation of mast cell activation (GO:0033003) | 3.29327378 |
| 70 | regulation of hypersensitivity (GO:0002883) | 3.25769963 |
| 71 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.25662668 |
| 72 | positive regulation of macrophage differentiation (GO:0045651) | 3.25101973 |
| 73 | T cell migration (GO:0072678) | 3.25016619 |
| 74 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.24843816 |
| 75 | B cell mediated immunity (GO:0019724) | 3.23400096 |
| 76 | regulation of B cell differentiation (GO:0045577) | 3.23001402 |
| 77 | macrophage activation (GO:0042116) | 3.18768336 |
| 78 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.18697682 |
| 79 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.18484057 |
| 80 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.18209385 |
| 81 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.17286080 |
| 82 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.14513210 |
| 83 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.14314113 |
| 84 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.14250059 |
| 85 | regulation of leukocyte degranulation (GO:0043300) | 3.13852778 |
| 86 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.13423955 |
| 87 | negative regulation of granulocyte differentiation (GO:0030853) | 3.13412952 |
| 88 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.13038842 |
| 89 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.11017427 |
| 90 | mast cell activation (GO:0045576) | 3.10414046 |
| 91 | negative regulation of interleukin-6 production (GO:0032715) | 3.10342714 |
| 92 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.02647055 |
| 93 | negative regulation of T cell mediated immunity (GO:0002710) | 3.02491096 |
| 94 | granulocyte chemotaxis (GO:0071621) | 2.99932517 |
| 95 | regulation of antigen processing and presentation (GO:0002577) | 2.99147109 |
| 96 | positive regulation of type 2 immune response (GO:0002830) | 2.98937189 |
| 97 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.98514607 |
| 98 | cytokine secretion (GO:0050663) | 2.97672617 |
| 99 | myeloid leukocyte mediated immunity (GO:0002444) | 2.97394770 |
| 100 | positive regulation of interferon-beta production (GO:0032728) | 2.94061483 |
| 101 | type I interferon signaling pathway (GO:0060337) | 2.93050306 |
| 102 | cellular response to type I interferon (GO:0071357) | 2.93050306 |
| 103 | response to type I interferon (GO:0034340) | 2.91492986 |
| 104 | myeloid dendritic cell activation (GO:0001773) | 2.91454633 |
| 105 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.90295386 |
| 106 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.89727716 |
| 107 | myeloid dendritic cell differentiation (GO:0043011) | 2.89230372 |
| 108 | granulocyte migration (GO:0097530) | 2.88557713 |
| 109 | leukocyte cell-cell adhesion (GO:0007159) | 2.86216477 |
| 110 | response to protozoan (GO:0001562) | 2.85796920 |
| 111 | eosinophil migration (GO:0072677) | 2.85652001 |
| 112 | myeloid leukocyte activation (GO:0002274) | 2.84057112 |
| 113 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.82141927 |
| 114 | positive regulation of interleukin-10 production (GO:0032733) | 2.81775569 |
| 115 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.81450080 |
| 116 | B cell receptor signaling pathway (GO:0050853) | 2.80892018 |
| 117 | * positive regulation of acute inflammatory response (GO:0002675) | 2.80550982 |
| 118 | actin nucleation (GO:0045010) | 2.78982394 |
| 119 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.76835089 |
| 120 | negative regulation of interleukin-1 production (GO:0032692) | 2.74514011 |
| 121 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.73969969 |
| 122 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.73921814 |
| 123 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.73385228 |
| 124 | positive regulation of B cell mediated immunity (GO:0002714) | 2.73385228 |
| 125 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.73101433 |
| 126 | NIK/NF-kappaB signaling (GO:0038061) | 2.72805608 |
| 127 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.72737701 |
| 128 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.69754508 |
| 129 | negative regulation of phagocytosis (GO:0050765) | 2.68836551 |
| 130 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.67350861 |
| 131 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.67344209 |
| 132 | pinocytosis (GO:0006907) | 2.67151810 |
| 133 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.66870905 |
| 134 | defense response to protozoan (GO:0042832) | 2.66305742 |
| 135 | response to laminar fluid shear stress (GO:0034616) | 2.65782113 |
| 136 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.64927850 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.91313945 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.88635383 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.87831802 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.75787886 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.72505306 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.57959657 |
| 7 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.57585377 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.56383864 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.36766982 |
| 10 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.25462545 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.19765937 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.19550910 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.13527092 |
| 14 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.89026020 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.76236152 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.73882312 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.71743059 |
| 18 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.65963196 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.56614641 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.55600703 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.55367953 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.42505164 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.34923650 |
| 24 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.33014011 |
| 25 | * MYB_26560356_Chip-Seq_TH2_Human | 2.32337690 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30249562 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 2.28775871 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 2.28120178 |
| 29 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.27933756 |
| 30 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.26814638 |
| 31 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.20518108 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.19531638 |
| 33 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.01947108 |
| 34 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.01650616 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 1.91584050 |
| 36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.89347846 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.86719887 |
| 38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.85091641 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.83639888 |
| 40 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.83330249 |
| 41 | UTX_26944678_Chip-Seq_JUKART_Human | 1.80845086 |
| 42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.76840842 |
| 43 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.75874004 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61914683 |
| 45 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57261842 |
| 46 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.56956691 |
| 47 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.56238842 |
| 48 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.55825962 |
| 49 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.54619350 |
| 50 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46634626 |
| 51 | MAF_26560356_Chip-Seq_TH2_Human | 1.44311777 |
| 52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41983021 |
| 53 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.40592509 |
| 54 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38081735 |
| 55 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.36892744 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36717425 |
| 57 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35668433 |
| 58 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33000450 |
| 59 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.28691593 |
| 60 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.27981792 |
| 61 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27308831 |
| 62 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.26092502 |
| 63 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.25560499 |
| 64 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23576347 |
| 65 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23137309 |
| 66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.20413661 |
| 67 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20003309 |
| 68 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19825980 |
| 69 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19064275 |
| 70 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.15125043 |
| 71 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.14012332 |
| 72 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13529368 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12106682 |
| 74 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11842081 |
| 75 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11022986 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07847348 |
| 77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06286350 |
| 78 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05967909 |
| 79 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.05777432 |
| 80 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.03338763 |
| 81 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.03338763 |
| 82 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.03338763 |
| 83 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02349235 |
| 84 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00406506 |
| 85 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95547902 |
| 86 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94369538 |
| 87 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.91875849 |
| 88 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.91829756 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89146931 |
| 90 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.85076470 |
| 91 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.84872331 |
| 92 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83051517 |
| 93 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83004426 |
| 94 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81811205 |
| 95 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.80178932 |
| 96 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80127512 |
| 97 | GATA2_19941826_ChIP-Seq_K562_Human | 0.79817083 |
| 98 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.79657759 |
| 99 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.78843296 |
| 100 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78376201 |
| 101 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.78125549 |
| 102 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.78076066 |
| 103 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.77098967 |
| 104 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76362511 |
| 105 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.75275703 |
| 106 | GATA1_22025678_ChIP-Seq_K562_Human | 0.72648184 |
| 107 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.72430795 |
| 108 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70368082 |
| 109 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.69873559 |
| 110 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.69517904 |
| 111 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.68200245 |
| 112 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.68188669 |
| 113 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66784820 |
| 114 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66506600 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.06118943 |
| 2 | MP0003436_decreased_susceptibility_to | 3.93179843 |
| 3 | MP0003303_peritoneal_inflammation | 3.76668360 |
| 4 | MP0005671_abnormal_response_to | 3.12216231 |
| 5 | MP0009785_altered_susceptibility_to | 3.06162732 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.04814208 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 3.04665601 |
| 8 | MP0004510_myositis | 3.02434621 |
| 9 | MP0002419_abnormal_innate_immunity | 2.96086631 |
| 10 | MP0006082_CNS_inflammation | 2.95369706 |
| 11 | MP0005025_abnormal_response_to | 2.79256346 |
| 12 | MP0001800_abnormal_humoral_immune | 2.76218051 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.72208695 |
| 14 | MP0005387_immune_system_phenotype | 2.69462856 |
| 15 | MP0001790_abnormal_immune_system | 2.69462856 |
| 16 | MP0002723_abnormal_immune_serum | 2.60612951 |
| 17 | MP0008004_abnormal_stomach_pH | 2.58025157 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.57739958 |
| 19 | MP0003724_increased_susceptibility_to | 2.53740266 |
| 20 | MP0000685_abnormal_immune_system | 2.51572984 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.44995976 |
| 22 | MP0001819_abnormal_immune_cell | 2.44091314 |
| 23 | MP0002405_respiratory_system_inflammati | 2.34216308 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.32925507 |
| 25 | MP0003300_gastrointestinal_ulcer | 2.09973942 |
| 26 | MP0001533_abnormal_skeleton_physiology | 2.03601611 |
| 27 | MP0001853_heart_inflammation | 2.02010749 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.99361789 |
| 29 | MP0009278_abnormal_bone_marrow | 1.96597613 |
| 30 | MP0009840_abnormal_foam_cell | 1.94340285 |
| 31 | MP0002398_abnormal_bone_marrow | 1.93900834 |
| 32 | MP0009333_abnormal_splenocyte_physiolog | 1.90762075 |
| 33 | MP0000716_abnormal_immune_system | 1.90192466 |
| 34 | MP0000343_altered_response_to | 1.89021039 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.87646756 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.86233251 |
| 37 | MP0000465_gastrointestinal_hemorrhage | 1.80548601 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.79612296 |
| 39 | MP0004947_skin_inflammation | 1.72122166 |
| 40 | MP0002396_abnormal_hematopoietic_system | 1.70522025 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.67974686 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.67974686 |
| 43 | MP0003448_altered_tumor_morphology | 1.65035736 |
| 44 | MP0008260_abnormal_autophagy | 1.63830293 |
| 45 | MP0002006_tumorigenesis | 1.63764847 |
| 46 | MP0002166_altered_tumor_susceptibility | 1.63321104 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.62060286 |
| 48 | MP0005076_abnormal_cell_differentiation | 1.61894786 |
| 49 | MP0002722_abnormal_immune_system | 1.60056821 |
| 50 | MP0002429_abnormal_blood_cell | 1.58716679 |
| 51 | MP0005310_abnormal_salivary_gland | 1.56400771 |
| 52 | MP0003763_abnormal_thymus_physiology | 1.56034242 |
| 53 | MP0008469_abnormal_protein_level | 1.53829155 |
| 54 | MP0001851_eye_inflammation | 1.47250580 |
| 55 | MP0001873_stomach_inflammation | 1.43972319 |
| 56 | MP0000858_altered_metastatic_potential | 1.42880891 |
| 57 | MP0009764_decreased_sensitivity_to | 1.42748532 |
| 58 | MP0005451_abnormal_body_composition | 1.33542641 |
| 59 | MP0004808_abnormal_hematopoietic_stem | 1.33218576 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.29453655 |
| 61 | MP0003075_altered_response_to | 1.21427047 |
| 62 | MP0002139_abnormal_hepatobiliary_system | 1.16267110 |
| 63 | MP0003828_pulmonary_edema | 1.15874445 |
| 64 | MP0000703_abnormal_thymus_morphology | 1.15048545 |
| 65 | MP0005166_decreased_susceptibility_to | 1.14235600 |
| 66 | MP0010307_abnormal_tumor_latency | 1.13238385 |
| 67 | MP0002933_joint_inflammation | 1.09930426 |
| 68 | MP0003866_abnormal_defecation | 1.08763856 |
| 69 | MP0000490_abnormal_crypts_of | 1.07734428 |
| 70 | MP0002332_abnormal_exercise_endurance | 1.06180905 |
| 71 | MP0003806_abnormal_nucleotide_metabolis | 1.03717120 |
| 72 | MP0005174_abnormal_tail_pigmentation | 1.01346667 |
| 73 | MP0002254_reproductive_system_inflammat | 1.00867430 |
| 74 | MP0005390_skeleton_phenotype | 0.98931887 |
| 75 | MP0000604_amyloidosis | 0.96094357 |
| 76 | MP0003566_abnormal_cell_adhesion | 0.92792934 |
| 77 | MP0010352_gastrointestinal_tract_polyps | 0.92010622 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 0.91171351 |
| 79 | MP0008057_abnormal_DNA_replication | 0.87983791 |
| 80 | MP0003690_abnormal_glial_cell | 0.87001628 |
| 81 | MP0009763_increased_sensitivity_to | 0.83031620 |
| 82 | MP0000249_abnormal_blood_vessel | 0.81360839 |
| 83 | MP0005167_abnormal_blood-brain_barrier | 0.78830377 |
| 84 | MP0005023_abnormal_wound_healing | 0.78656784 |
| 85 | MP0003183_abnormal_peptide_metabolism | 0.77841549 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 0.77084341 |
| 87 | MP0005164_abnormal_response_to | 0.76952288 |
| 88 | MP0001663_abnormal_digestive_system | 0.76865711 |
| 89 | MP0002019_abnormal_tumor_incidence | 0.74067180 |
| 90 | MP0008873_increased_physiological_sensi | 0.73363929 |
| 91 | MP0001727_abnormal_embryo_implantation | 0.71352983 |
| 92 | MP0006054_spinal_hemorrhage | 0.71176299 |
| 93 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70943455 |
| 94 | MP0003795_abnormal_bone_structure | 0.68835110 |
| 95 | MP0004883_abnormal_blood_vessel | 0.66656224 |
| 96 | MP0001915_intracranial_hemorrhage | 0.66496437 |
| 97 | MP0002132_abnormal_respiratory_system | 0.66453189 |
| 98 | MP0003045_fibrosis | 0.63796684 |
| 99 | MP0000750_abnormal_muscle_regeneration | 0.63344711 |
| 100 | MP0005535_abnormal_body_temperature | 0.60552952 |
| 101 | MP0000569_abnormal_digit_pigmentation | 0.59325407 |
| 102 | MP0002277_abnormal_respiratory_mucosa | 0.57620623 |
| 103 | MP0000609_abnormal_liver_physiology | 0.57246001 |
| 104 | MP0005165_increased_susceptibility_to | 0.54376518 |
| 105 | MP0009765_abnormal_xenobiotic_induced | 0.53662351 |
| 106 | MP0000371_diluted_coat_color | 0.52461989 |
| 107 | MP0008874_decreased_physiological_sensi | 0.52082527 |
| 108 | MP0005319_abnormal_enzyme/_coenzyme | 0.51078951 |
| 109 | MP0003656_abnormal_erythrocyte_physiolo | 0.49797166 |
| 110 | MP0002136_abnormal_kidney_physiology | 0.49128423 |
| 111 | MP0005666_abnormal_adipose_tissue | 0.49014660 |
| 112 | MP0002009_preneoplasia | 0.48806575 |
| 113 | MP0008007_abnormal_cellular_replicative | 0.48784502 |
| 114 | MP0004484_altered_response_of | 0.48499344 |
| 115 | MP0003077_abnormal_cell_cycle | 0.47762371 |
| 116 | MP0000313_abnormal_cell_death | 0.47296369 |
| 117 | MP0003279_aneurysm | 0.46984151 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.82772420 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.30467750 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.15137455 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.90281861 |
| 5 | Abnormality of macrophages (HP:0004311) | 4.59009370 |
| 6 | Myositis (HP:0100614) | 4.50361847 |
| 7 | Recurrent fungal infections (HP:0002841) | 4.48811577 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.31712856 |
| 9 | Recurrent skin infections (HP:0001581) | 4.14449314 |
| 10 | Orchitis (HP:0100796) | 4.10217913 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 4.04451158 |
| 12 | Stomatitis (HP:0010280) | 4.03075397 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 3.85862227 |
| 14 | Obstructive lung disease (HP:0006536) | 3.85862227 |
| 15 | Optic neuritis (HP:0100653) | 3.75165586 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 3.75165586 |
| 17 | Chronic otitis media (HP:0000389) | 3.72844981 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 3.62791584 |
| 19 | Pustule (HP:0200039) | 3.60245334 |
| 20 | Petechiae (HP:0000967) | 3.59797050 |
| 21 | Recurrent viral infections (HP:0004429) | 3.59077754 |
| 22 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.53232953 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.46887849 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.46887849 |
| 25 | Gingivitis (HP:0000230) | 3.46080873 |
| 26 | Amyloidosis (HP:0011034) | 3.45768491 |
| 27 | Nasal polyposis (HP:0100582) | 3.32733111 |
| 28 | Cellulitis (HP:0100658) | 3.31792453 |
| 29 | Systemic lupus erythematosus (HP:0002725) | 3.31061901 |
| 30 | IgM deficiency (HP:0002850) | 3.28289016 |
| 31 | Impaired platelet aggregation (HP:0003540) | 3.24230859 |
| 32 | Abnormal platelet function (HP:0011869) | 3.24230859 |
| 33 | Prolonged bleeding time (HP:0003010) | 3.23383151 |
| 34 | Spontaneous hematomas (HP:0007420) | 3.18533276 |
| 35 | Abnormality of glycolipid metabolism (HP:0010969) | 3.17377439 |
| 36 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.17377439 |
| 37 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.17377439 |
| 38 | Episodic fever (HP:0001954) | 3.08773833 |
| 39 | Vacuolated lymphocytes (HP:0001922) | 3.07591549 |
| 40 | Gangrene (HP:0100758) | 3.06129886 |
| 41 | Meningitis (HP:0001287) | 3.00718470 |
| 42 | Vasculitis (HP:0002633) | 2.97900533 |
| 43 | Periodontitis (HP:0000704) | 2.96209264 |
| 44 | Prostate neoplasm (HP:0100787) | 2.91480188 |
| 45 | Abnormality of the nasal mucosa (HP:0000433) | 2.90251933 |
| 46 | Inflammation of the large intestine (HP:0002037) | 2.88473058 |
| 47 | Gingival bleeding (HP:0000225) | 2.81768248 |
| 48 | Leukocytosis (HP:0001974) | 2.81511780 |
| 49 | Epistaxis (HP:0000421) | 2.78947370 |
| 50 | Gastrointestinal inflammation (HP:0004386) | 2.75049957 |
| 51 | Recurrent bronchitis (HP:0002837) | 2.74747540 |
| 52 | T lymphocytopenia (HP:0005403) | 2.73628153 |
| 53 | Abnormality of T cell number (HP:0011839) | 2.73307250 |
| 54 | Increased serum ferritin (HP:0003281) | 2.72959408 |
| 55 | Pulmonary embolism (HP:0002204) | 2.70783889 |
| 56 | Loss of speech (HP:0002371) | 2.69916335 |
| 57 | Glomerulonephritis (HP:0000099) | 2.66945023 |
| 58 | Urticaria (HP:0001025) | 2.63646261 |
| 59 | Autoimmune thrombocytopenia (HP:0001973) | 2.61268750 |
| 60 | Pulmonary infiltrates (HP:0002113) | 2.60173022 |
| 61 | Colitis (HP:0002583) | 2.57723673 |
| 62 | Agnosia (HP:0010524) | 2.56644417 |
| 63 | Purpura (HP:0000979) | 2.56557022 |
| 64 | Abnormality of T cells (HP:0002843) | 2.56151660 |
| 65 | Hematochezia (HP:0002573) | 2.55533677 |
| 66 | Abnormality of the pleura (HP:0002103) | 2.54013586 |
| 67 | Autoimmune hemolytic anemia (HP:0001890) | 2.53215963 |
| 68 | Arterial thrombosis (HP:0004420) | 2.52907987 |
| 69 | Disinhibition (HP:0000734) | 2.52020963 |
| 70 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.51983668 |
| 71 | Axonal loss (HP:0003447) | 2.51316918 |
| 72 | Hemoptysis (HP:0002105) | 2.47223385 |
| 73 | Dysostosis multiplex (HP:0000943) | 2.44916353 |
| 74 | Basal ganglia calcification (HP:0002135) | 2.44756218 |
| 75 | Osteolytic defects of the hand bones (HP:0009699) | 2.44318094 |
| 76 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.44318094 |
| 77 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.43901812 |
| 78 | Glomerulopathy (HP:0100820) | 2.41687726 |
| 79 | Interstitial pulmonary disease (HP:0006530) | 2.40922730 |
| 80 | Granulocytopenia (HP:0001913) | 2.39299205 |
| 81 | Chronic diarrhea (HP:0002028) | 2.38018454 |
| 82 | Myocardial infarction (HP:0001658) | 2.37097833 |
| 83 | Cheilitis (HP:0100825) | 2.36402030 |
| 84 | Abnormality of T cell physiology (HP:0011840) | 2.36168374 |
| 85 | Vertigo (HP:0002321) | 2.35507030 |
| 86 | Polyneuropathy (HP:0001271) | 2.34261291 |
| 87 | Abnormality of the peritoneum (HP:0002585) | 2.33560646 |
| 88 | Abnormality of the prostate (HP:0008775) | 2.33483966 |
| 89 | Keratoconjunctivitis sicca (HP:0001097) | 2.29773602 |
| 90 | Menorrhagia (HP:0000132) | 2.27929055 |
| 91 | Abnormality of iron homeostasis (HP:0011031) | 2.27024766 |
| 92 | Abnormality of the endocardium (HP:0004306) | 2.26687401 |
| 93 | Osteomyelitis (HP:0002754) | 2.25527349 |
| 94 | Keratitis (HP:0000491) | 2.21740283 |
| 95 | Peritonitis (HP:0002586) | 2.21462875 |
| 96 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.21448982 |
| 97 | Increased IgE level (HP:0003212) | 2.18142786 |
| 98 | Panhypogammaglobulinemia (HP:0003139) | 2.17741800 |
| 99 | Abnormal platelet volume (HP:0011876) | 2.15875161 |
| 100 | Encephalitis (HP:0002383) | 2.15609500 |
| 101 | Chest pain (HP:0100749) | 2.14076835 |
| 102 | Acne (HP:0001061) | 2.12386602 |
| 103 | Premature loss of primary teeth (HP:0006323) | 2.12064365 |
| 104 | Thrombocytosis (HP:0001894) | 2.09242382 |
| 105 | Anorexia (HP:0002039) | 2.08415363 |
| 106 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.06651013 |
| 107 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.06651013 |
| 108 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.06651013 |
| 109 | Gastrointestinal infarctions (HP:0005244) | 2.06632285 |
| 110 | Eosinophilia (HP:0001880) | 2.06122892 |
| 111 | Keratoconjunctivitis (HP:0001096) | 2.05552409 |
| 112 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.05512444 |
| 113 | Abnormality of eosinophils (HP:0001879) | 2.03001747 |
| 114 | Combined immunodeficiency (HP:0005387) | 2.02463337 |
| 115 | Hypergammaglobulinemia (HP:0010702) | 2.02188850 |
| 116 | Skin ulcer (HP:0200042) | 2.01611120 |
| 117 | Joint swelling (HP:0001386) | 1.99883224 |
| 118 | Thyroiditis (HP:0100646) | 1.98316946 |
| 119 | Increased IgM level (HP:0003496) | 1.97704833 |
| 120 | Recurrent pneumonia (HP:0006532) | 1.97481179 |
| 121 | Arthralgia (HP:0002829) | 1.97209934 |
| 122 | Mucopolysacchariduria (HP:0008155) | 1.96340121 |
| 123 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.96340121 |
| 124 | Thick nail (HP:0001805) | 1.96001702 |
| 125 | Thrombophlebitis (HP:0004418) | 1.92198597 |
| 126 | Polygenic inheritance (HP:0010982) | 1.89897155 |
| 127 | Sepsis (HP:0100806) | 1.89803356 |
| 128 | Hepatosplenomegaly (HP:0001433) | 1.89748539 |
| 129 | Increased CSF protein (HP:0002922) | 1.87704770 |
| 130 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85620306 |
| 131 | Skin rash (HP:0000988) | 1.84302116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.61946463 |
| 2 | MAP3K14 | 3.21238497 |
| 3 | BLK | 3.12656825 |
| 4 | TYK2 | 3.09356622 |
| 5 | TXK | 3.09061556 |
| 6 | TBK1 | 2.83005412 |
| 7 | IKBKE | 2.72090310 |
| 8 | KIT | 2.61183249 |
| 9 | PRPF4B | 2.42610328 |
| 10 | JAK3 | 2.28704111 |
| 11 | IKBKB | 2.17687112 |
| 12 | IRAK1 | 2.17022662 |
| 13 | RIPK4 | 2.15249637 |
| 14 | ZAP70 | 2.13522413 |
| 15 | ERN1 | 2.11016897 |
| 16 | MAP3K10 | 2.09411594 |
| 17 | PIM2 | 2.07259530 |
| 18 | IRAK4 | 2.03467125 |
| 19 | STK10 | 1.96022156 |
| 20 | TAOK2 | 1.94313745 |
| 21 | IRAK3 | 1.93625696 |
| 22 | IRAK2 | 1.92724873 |
| 23 | TGFBR2 | 1.92319224 |
| 24 | GRK6 | 1.88924506 |
| 25 | JAK1 | 1.85455398 |
| 26 | PIM1 | 1.82662580 |
| 27 | EPHB1 | 1.62990058 |
| 28 | MAP3K1 | 1.61073023 |
| 29 | CSK | 1.60444543 |
| 30 | BMPR2 | 1.59516075 |
| 31 | FGFR4 | 1.54757948 |
| 32 | CSF1R | 1.50216443 |
| 33 | SYK | 1.43013339 |
| 34 | FES | 1.41123337 |
| 35 | MATK | 1.39069173 |
| 36 | ITK | 1.37376967 |
| 37 | NEK9 | 1.36327661 |
| 38 | BTK | 1.35778578 |
| 39 | FGFR3 | 1.34759939 |
| 40 | CHUK | 1.26647914 |
| 41 | HCK | 1.24015153 |
| 42 | EEF2K | 1.23183729 |
| 43 | RPS6KA4 | 1.23167116 |
| 44 | JAK2 | 1.18649798 |
| 45 | LCK | 1.17843528 |
| 46 | TNK2 | 1.15471582 |
| 47 | TEC | 1.14997906 |
| 48 | LYN | 1.12425951 |
| 49 | TAOK3 | 1.03124868 |
| 50 | TRIB3 | 1.00286277 |
| 51 | KSR2 | 0.98825662 |
| 52 | PIK3CG | 0.97779909 |
| 53 | TESK2 | 0.96388128 |
| 54 | MAP2K3 | 0.95666649 |
| 55 | SCYL2 | 0.94286622 |
| 56 | SIK3 | 0.93641140 |
| 57 | CDK12 | 0.92720376 |
| 58 | CLK1 | 0.91392420 |
| 59 | CDK6 | 0.90724391 |
| 60 | CDC42BPA | 0.89878121 |
| 61 | MAP3K11 | 0.88292718 |
| 62 | MAP3K5 | 0.85927269 |
| 63 | MAP3K13 | 0.84866779 |
| 64 | MST4 | 0.83539382 |
| 65 | BMX | 0.82606999 |
| 66 | LRRK2 | 0.82167019 |
| 67 | KDR | 0.79387900 |
| 68 | FGR | 0.78263073 |
| 69 | PAK4 | 0.75798503 |
| 70 | PDK2 | 0.74361313 |
| 71 | MARK3 | 0.72711040 |
| 72 | RPS6KA6 | 0.71490597 |
| 73 | MAP3K6 | 0.68574205 |
| 74 | MAPK7 | 0.65963854 |
| 75 | MAPKAPK2 | 0.64849014 |
| 76 | GRK7 | 0.63659382 |
| 77 | SIK2 | 0.61464360 |
| 78 | MAPK4 | 0.59128737 |
| 79 | RPS6KL1 | 0.59082951 |
| 80 | RPS6KC1 | 0.59082951 |
| 81 | NME2 | 0.58905919 |
| 82 | MAP2K6 | 0.55865236 |
| 83 | PKN2 | 0.54861893 |
| 84 | RPS6KA5 | 0.54515643 |
| 85 | TRPM7 | 0.52056356 |
| 86 | MAP3K3 | 0.51072531 |
| 87 | MARK2 | 0.50010369 |
| 88 | EGFR | 0.48866118 |
| 89 | ACVR1B | 0.47992427 |
| 90 | STK24 | 0.47729590 |
| 91 | PDK1 | 0.47699850 |
| 92 | NEK2 | 0.47663856 |
| 93 | STK4 | 0.47546462 |
| 94 | PRKCD | 0.47250304 |
| 95 | PDPK1 | 0.46604888 |
| 96 | MAP2K2 | 0.45116720 |
| 97 | DDR2 | 0.44731343 |
| 98 | HIPK2 | 0.44099970 |
| 99 | TAOK1 | 0.43010140 |
| 100 | ABL2 | 0.42644698 |
| 101 | ABL1 | 0.41630923 |
| 102 | PTK6 | 0.40704921 |
| 103 | RAF1 | 0.40438408 |
| 104 | ALK | 0.40141957 |
| 105 | FYN | 0.39309079 |
| 106 | MAP3K8 | 0.39260762 |
| 107 | MOS | 0.39188161 |
| 108 | CAMK1D | 0.39033661 |
| 109 | DMPK | 0.39029723 |
| 110 | DAPK2 | 0.37885418 |
| 111 | CDK4 | 0.37566189 |
| 112 | FLT3 | 0.37464459 |
| 113 | PRKCQ | 0.35355322 |
| 114 | RPS6KA1 | 0.35012703 |
| 115 | MAPK12 | 0.33293514 |
| 116 | PRKD2 | 0.33263039 |
| 117 | EPHA3 | 0.32613942 |
| 118 | YES1 | 0.32317327 |
| 119 | TSSK6 | 0.32021242 |
| 120 | EIF2AK2 | 0.31594645 |
| 121 | RIPK1 | 0.30276892 |
| 122 | MAPK11 | 0.29767466 |
| 123 | MAPK3 | 0.27509675 |
| 124 | ARAF | 0.27052804 |
| 125 | MAP3K2 | 0.26648698 |
| 126 | GSK3A | 0.25925337 |
| 127 | PRKAA2 | 0.24058958 |
| 128 | PRKG2 | 0.23432042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 3.45113269 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.19054809 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.90801835 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.73188686 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.61773931 |
| 6 | Legionellosis_Homo sapiens_hsa05134 | 2.55800956 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.39610742 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.31973374 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.27758172 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.22032587 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.08852740 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.08414674 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.08103853 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 2.04853813 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.91041450 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.89512398 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.86601747 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.83354595 |
| 19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.77064327 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.75203375 |
| 21 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.73782638 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.70973356 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.69285155 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.67802198 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.67415069 |
| 26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.65304935 |
| 27 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.60441068 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.59570487 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.58246558 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.56501422 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.55223914 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.53621268 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.49389639 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.49232543 |
| 35 | Salmonella infection_Homo sapiens_hsa05132 | 1.48584688 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.48201528 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.47729279 |
| 38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.46957525 |
| 39 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.45801417 |
| 40 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.40668272 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.39495659 |
| 42 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.27926636 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.26808783 |
| 44 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.23637253 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 1.20834284 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.19820784 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14559861 |
| 48 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.14557768 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.09525966 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.08639315 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.03437058 |
| 52 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.03367219 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.96023170 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.95331801 |
| 55 | Bladder cancer_Homo sapiens_hsa05219 | 0.94889477 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.93553715 |
| 57 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.79839414 |
| 58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78916724 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.76909321 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76839217 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75947506 |
| 62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.74918068 |
| 63 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.69480277 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.69267046 |
| 65 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60991566 |
| 66 | Amoebiasis_Homo sapiens_hsa05146 | 0.59809961 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59683232 |
| 68 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59665702 |
| 69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58694342 |
| 70 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.57806739 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57585722 |
| 72 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56755589 |
| 73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.55936567 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55411781 |
| 75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54244064 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52195492 |
| 77 | Endocytosis_Homo sapiens_hsa04144 | 0.47645713 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46166966 |
| 79 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.44979169 |
| 80 | DNA replication_Homo sapiens_hsa03030 | 0.44410459 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43374790 |
| 82 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.41788599 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41602308 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41532774 |
| 85 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41219634 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40464346 |
| 87 | Base excision repair_Homo sapiens_hsa03410 | 0.39197660 |
| 88 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39042704 |
| 89 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.38504525 |
| 90 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38366788 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.37366602 |
| 92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36476548 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35661925 |
| 94 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.32803333 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31570162 |
| 96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29879361 |
| 97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.29535124 |
| 98 | Ribosome_Homo sapiens_hsa03010 | 0.27287260 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.26310490 |
| 100 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.25683973 |
| 101 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.24371758 |
| 102 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.22302607 |
| 103 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.21482569 |
| 104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.21236170 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.21000319 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.20805778 |
| 107 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.20610709 |
| 108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.20091011 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.19699994 |
| 110 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.18977549 |
| 111 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.18917759 |
| 112 | Endometrial cancer_Homo sapiens_hsa05213 | 0.17493464 |
| 113 | Prostate cancer_Homo sapiens_hsa05215 | 0.16558897 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.15526856 |
| 115 | Insulin resistance_Homo sapiens_hsa04931 | 0.15415287 |
| 116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.15336085 |
| 117 | Pathways in cancer_Homo sapiens_hsa05200 | 0.14317580 |

